Neuraltus is a developer of small molecule therapeutics for the treatment of neurodegenerative diseases.
Neuraltus Pharmaceuticals Inc.
Facts from the Community
From the BioVenturist base
Technology Focus:
Medical focus:
View entire collection »Investment Round:
| Investment round | Amount raised | Currency | Date | Investors | web reference |
|---|---|---|---|---|---|
|
|
We can tell you that Neuraltus Pharmaceuticals Inc. is a…
If you know more about Neuraltus Pharmaceuticals Inc., you can add more facts here »
Similar topics in Freebase
-
Zacharon Pharmaceuticals Inc.
Zacharon is developing small-molecule glycan inhibitors. -
Alios BioPharma Inc.
Alios is developing novel therapeutics that treat disease in virology by activating the innate immune system. -
Anacor Pharmaceuticals Inc.
Anacor Pharmaceuticals is developing small-molecule therapeutics using their boron chemistry platform. -
Knopp Neurosciences Inc.
Knopp Neurosciences develops biomarkers and therapeutics for Amyotrophic Lateral Sclerosis. -
Qwell Pharmaceuticals
Qwell Pharmaceuticals is developing plant-derived small molecule therapeutics. -
AC Immune SA
AC Immune is a clinical stage therapeutics company focused on Alzheimer's Disease. The currently are developing vaccines, antibodies, and small molecules for the disease.
